Ataxia telangiectasia (AT) is a recessively inherited disorder showing progressive cerebellar degeneration in which patients are predisposed to developing lymphoid tumours."' A gene for ataxia telangiactasia has been mapped to chromosome llq22-23,15 a region associated with neurological and immune function loci. In view of reports of at least four complementation groups, AB, C, D, and E,5a there may be a number of genes in this chromosome segment. It is clear, however, that the AT locus for patients in groups AB, and C is at 1 1 q22-2336 and both may be between NCAM/DRD2 and STMY/D11 S385. 7 Fibroblasts from a group D patient have been complemented by chromosome 11 microcell fusion89 and the group D gene may be distal to THY-I between D11S147 and D11S133.7'0 One group E family we have studied did not provide any support for the existence of this AT locus outside the 1 1q22-23 region. 5 In addition to the evidence for genetic heterogeneity as shown by complementation, there is also evidence for cellular heterogeneity in AT. About 10 to 15% of subjects show a much smaller increase in radiosensitivity compared with other AT patients as measured chromosomally and by colony forming assays." 12 The clinical features of AT are progressive cerebellar ataxia, oculomotor apraxia, an expressionless face, choreoathetosis, dysarthria, peripheral neuropathy, and ocular telangiectasia.' Clinical heterogeneity may be observed. The progressive cerebellar de- generation usually begins in infancy or early childhood' but the age of onset may vary up to the age of about 12 years.'3 The rate of progress of the disorder may be variable and the presence of bulbar telangiectasia is also variable.
In the present study we After exposure of lymphocytes to both 0 5 Gray and 1 0 Gray x rays in the G2 phase of the cell cycle, both patients showed the large in- In this inbred family it was expected that both affected subjects would show similar haplotypes and a high degree of homozygosity. Ninety percent homozygosity was observed in patient II.8 but not in II.7. Patient II.8 inherited chromosome C, which both parents of the AT children also shared but was not present in II.7. In the larger side of the family, II.7 showed the same haplotype as a phenotypically normal sib, II.6. In 50 families haplotyped this is the only instance we have encountered where an apparently identical haplotype in unaffected and affected subjects cannot easily be explained on the basis of a single recombination event5 (unpublished results). The proband II.7 has not inherited the maternal chromosome C which in her cousin appears to contribute to AT, but instead has a different haplotype. One explanation of this is that she is homozygous for a gene at a different locus, and therefore the extended family may be carrying more than one mutation for AT. If separate loci were responsible for the AT seen in this family then phenotypic differences might be expected between the cousins. Minor differences, for example, height and drooling, exist, but the similarities appear stronger, and this especially applies to the cellular radiosensitivity.
The possibility of a rare double recombination between the maternal chromosomes would theoretically explain the haplotype similarity between II.6 and II.7 and the difference from II.8. The recombination would have to occur telomeric to NCAM/DRD2 because the combination B/C in this region is the only haplotype not presented in an unaffected subject. This is of interest because haplotype analysis of other reported families probably places AT group AB and group C centromeric to NCAM/DRD2.57 Some evidence suggests that the locus for complemen-tation group D patients may be in the more telomeric region'0 between markers DIIS147 and DII S133, which are distal to THY-1. At present the simplest way in which to interpret the observations presented here is that in this family the gene for AT is not on chromosome 1 Iq22-23.
